BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company's adult stem cell treatment for ALS. The Mayo Clinic is the third leading U.S. clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said on Monday.
Additional Coverage: Yahoo! News, Chicago Tribune
Tags: A.L.S., BrainStorm Cell Therapeutics, clinical trial, Industry News & Competitive Intelligence, Mayo Clinic Rochester, Research, Reuters, stem cell therapy, stem-cell